In Vitro Protein Expression Systems

Global Market Trajectory & Analytics

MCP12551

EXECUTIVE ENGAGEMENTS

POOL

832
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

166
Interactions with Platform & by Email

PARTICIPANTS

33
Unique # Participated

VALIDATIONS

9
Responses Validated*

COMPANIES

10
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

108

PAGES

148

EDITION

8

PRICE

USD 4950

CODE

MCP12551


COMPETITIVE METRICS

COMPANY

D S N T

% *

Bioneer Corporation

biotechrabbit GmbH

CellFree Sciences Co., Ltd.

Cube Biotech GmbH

GeneCopoeia, Inc.

Jena Bioscience GmbH

New England Biolabs, Inc.

Promega Corporation

Takara Bio, Inc.

Thermo Fisher Scientific, Inc.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for In Vitro Protein Expression Systems estimated at US$170.8 Million in the year 2020, is projected to reach a revised size of US$234.3 Million by 2027, growing at a CAGR of 4.6% over the analysis period 2020-2027. E-coli In-Vitro Protein Expression System, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$124.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mammalian In-Vitro Protein Expression System segment is readjusted to a revised 4.3% CAGR for the next 7-year period.
The In Vitro Protein Expression Systems market in the U.S. is estimated at US$50.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$41.4 Million by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.
In the global Other Product Types segment, USA, Canada, Japan, China and Europe will drive the 4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$37.7 Million in the year 2020 will reach a projected size of US$49.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$26.8 Million by the year 2027.

SELECT PLAYERS

Bioneer Corporation; biotechrabbit GmbH; CellFree Sciences Co., Ltd.; Cube Biotech GmbH; GeneCopoeia, Inc.; Jena Bioscience GmbH; New England Biolabs, Inc.; Promega Corporation; Takara Bio, Inc.; Thermo Fisher Scientific, Inc.

SEGMENTS

» End-Use (Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs), Academic and Research Institutes) » Product Type (E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System, Other Product Types)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for In Vitro Protein Expression Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for E-coli In-Vitro Protein Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for E-coli In-Vitro Protein Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for E-coli In-Vitro Protein Expression System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Mammalian In-Vitro Protein Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Mammalian In-Vitro Protein Expression System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Mammalian In-Vitro Protein Expression System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Biotechnological Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Biotechnological Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biotechnological Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
World Historic Review for Academic and Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic and Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
USA Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
USA Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Canada Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Japan Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
China Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
China Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
Europe Historic Review for In Vitro Protein Expression Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In Vitro Protein Expression Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
France Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
France Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Germany Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Italy Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
UK Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
UK Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for In Vitro Protein Expression Systems by Product Type - E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for In Vitro Protein Expression Systems by Product Type - Percentage Breakdown of Value Sales for E-coli In-Vitro Protein Expression System, Mammalian In-Vitro Protein Expression System and Other Product Types for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for In Vitro Protein Expression Systems by End-Use - Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for In Vitro Protein Expression Systems by End-Use - Percentage Breakdown of Value Sales for Biotechnological Companies, Pharmaceutical Companies, Contract Research Organizations (CROs) and Academic and Research Institutes for the Years 2012, 2020 & 2027
Total Companies Profiled: 10

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com